全文获取类型
收费全文 | 7655篇 |
免费 | 314篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 296篇 |
妇产科学 | 158篇 |
基础医学 | 479篇 |
口腔科学 | 97篇 |
临床医学 | 949篇 |
内科学 | 1185篇 |
皮肤病学 | 23篇 |
神经病学 | 434篇 |
特种医学 | 175篇 |
外科学 | 823篇 |
综合类 | 106篇 |
一般理论 | 1篇 |
预防医学 | 2542篇 |
眼科学 | 79篇 |
药学 | 301篇 |
中国医学 | 2篇 |
肿瘤学 | 328篇 |
出版年
2024年 | 6篇 |
2023年 | 621篇 |
2022年 | 879篇 |
2021年 | 695篇 |
2020年 | 830篇 |
2019年 | 390篇 |
2018年 | 354篇 |
2017年 | 357篇 |
2016年 | 397篇 |
2015年 | 364篇 |
2014年 | 600篇 |
2013年 | 438篇 |
2012年 | 288篇 |
2011年 | 189篇 |
2010年 | 294篇 |
2009年 | 328篇 |
2008年 | 144篇 |
2007年 | 132篇 |
2006年 | 97篇 |
2005年 | 82篇 |
2004年 | 33篇 |
2003年 | 41篇 |
2002年 | 55篇 |
2001年 | 49篇 |
2000年 | 32篇 |
1999年 | 46篇 |
1998年 | 44篇 |
1997年 | 21篇 |
1996年 | 38篇 |
1995年 | 30篇 |
1994年 | 20篇 |
1993年 | 14篇 |
1992年 | 4篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 5篇 |
1988年 | 8篇 |
1987年 | 10篇 |
1986年 | 18篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1976年 | 2篇 |
排序方式: 共有7991条查询结果,搜索用时 0 毫秒
131.
132.
《Journal of cardiac failure》2021,27(12):1374-1381
BackgroundIn the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial, vericiguat reduced the risk of mortality due to cardiovascular problems and of hospitalization due to heart failure (HF) among patients with HF with reduced ejection fraction (HFrEF) and recent worsening HF events (WHFEs). The representativeness of the VICTORIA population of patients with WHFE in clinical practice is unknown.Methods and ResultsPatients with HF and ejection fraction <45% were identified in the Practice Innovation And Clinical Excellence (PINNACLE) registry and were stratified by the occurrence of WHFEs. Characteristics and outcomes of patients in the PINNACLE registry with and without WHFEs were compared to the VICTORIA population. Of the 14,180 PINNACLE patients identified with HFrEF, 26.5% had had a WHFE. The VICTORIA population was similar to PINNACLE patients with WHFEs in mean age (67.3 vs 66.7), ejection fraction (28.9% vs 28.3%), body mass index (26.8 vs 27.6), and comorbidity burden. The rate of hospitalization because of HF at 1 year was 29.6% in the placebo group of VICTORIA, compared to 35.8% in PINNACLE patients with WHFEs and 13.3% in patients without WHFEs.ConclusionsThe PINNACLE patients with WHFEs meeting the VICTORIA definition resembled the VICTORIA population in characteristics and outcomes, suggesting that VICTORIA's population may be generalizable to patients with WHFEs in clinical practice. 相似文献
133.
134.
135.
《Patient education and counseling》2021,104(11):2648-2649
An experience that occurred during an obstetrics 3rd year clerkship on the postpartum wards elaborates on and reflects upon the interaction between a student and patient.The stressful interaction and ultimate resolution underpin the sometimes critical moments in education that help define patient-physician relationships. 相似文献
136.
137.
Shiwani Mahajan César Caraballo Shu-Xia Li Yike Dong Lian Chen Sara K. Huston Rajesh Srinivasan Carrie A. Redlich Albert I. Ko Jeremy S. Faust Howard P. Forman Harlan M. Krumholz 《The American journal of medicine》2021,134(6):812-816.e2
BackgroundInfection fatality rate and infection hospitalization rate, defined as the proportion of deaths and hospitalizations, respectively, of the total infected individuals, can estimate the actual toll of coronavirus disease 2019 (COVID-19) on a community, as the denominator is ideally based on a representative sample of a population, which captures the full spectrum of illness, including asymptomatic and untested individuals.ObjectiveTo determine the COVID-19 infection hospitalization rate and infection fatality rate among the non-congregate population in Connecticut between March 1 and June 1, 2020.MethodsThe infection hospitalization rate and infection fatality rate were calculated for adults residing in non-congregate settings in Connecticut prior to June 2020. Individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies were estimated using the seroprevalence estimates from the recently conducted Post-Infection Prevalence study. Information on total hospitalizations and deaths was obtained from the Connecticut Hospital Association and the Connecticut Department of Public Health, respectively.ResultsPrior to June 1, 2020, nearly 113,515 (90% confidence interval [CI] 56,758-170,273) individuals were estimated to have SARS-CoV-2 antibodies, and there were 7792 hospitalizations and 1079 deaths among the non-congregate population. The overall COVID-19 infection hospitalization rate and infection fatality rate were estimated to be 6.86% (90% CI, 4.58%-13.72%) and 0.95% (90% CI, 0.63%-1.90%), respectively, and there was variation in these rate estimates across subgroups; older people, men, non-Hispanic Black people, and those belonging to 2 of the counties had a higher burden of adverse outcomes, although the differences between most subgroups were not statistically significant.ConclusionsUsing representative seroprevalence estimates, the overall COVID-19 infection hospitalization rate and infection fatality rate were estimated to be 6.86% and 0.95%, respectively, among community residents in Connecticut. 相似文献
138.
Habers G. Esther A. van der Helm-van Mil Annette H. M. Veldhuijzen Dieuwke S. Allaart Cornelia F. Vreugdenhil Erno Starreveld Daniëlle E. J. Huizinga Tom W. J. Evers Andrea W. M. 《Clinical rheumatology》2021,40(6):2185-2192
Clinical Rheumatology - Rheumatoid arthritis (RA) patients show an earlier circadian rhythm (i.e. serum melatonin peaks earlier during the night, indicating an earlier timing of the internal... 相似文献
139.
140.